<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24474121</article-id>
      <article-id pub-id-type="pmc">3900363</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132178</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Syndrome In Question</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Do you know this syndrome?<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Voc&#xEA; conhece esta s&#xED;ndrome?</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Machado</surname>
            <given-names>Pedro Vale</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Daxbacher</surname>
            <given-names>Egon Luiz Rodrigues</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Obadia</surname>
            <given-names>Daniel Lago</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>da Cunha</surname>
            <given-names>Edna Ferreira</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alves</surname>
            <given-names>Maria de F&#xE1;tima Guimar&#xE3;es Scotelaro</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mann</surname>
            <given-names>Danielle</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> Specialist in Dermatology. Postgraduate degree in Dermatology from the
Pedro Ernesto University Hospital - Rio de Janeiro State University (HUPE-UERJ) - Rio de
Janeiro (RJ), Brazil.</aff>
      <aff id="aff02"><label>2</label> Preceptor of Dermatology, Pedro Ernesto University Hospital - Rio de
Janeiro State University (HUPE-UERJ) - Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff03"><label>3</label> Professor of Pediatrics, Pedro Ernesto University Hospital - Rio de
Janeiro State University (HUPE-UERJ) - Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff04"><label>4</label> Specialist in Dermatology. Doctor in general medicine at the Lagoa
Federal Hospital- Rio de Janeiro (RJ), Brazil.</aff>
      <author-notes>
        <corresp id="c01"><bold>MAILING ADDRESS:</bold> Pedro Vale Machado, Av. 28 de setembro, 77. 2&#xBA; andar,
Vila Isabel, 20551-030 - Rio de Janeiro - RJ, Brazil. E-mail:
<email>pedrovalemachado@yahoo.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6</issue>
      <fpage>1011</fpage>
      <lpage>1013</lpage>
      <history>
        <date date-type="received">
          <day>06</day>
          <month>10</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>11</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>Berardinelli-Seip syndrome is a rare autosomal recessive disease characterized by
inadequate metabolism and inefficient storing of lipids in fat cells, generating
accumulation of fat in organs such as the liver, spleen, pancreas, heart, arterial
endothelium and skin. Classically, patients manifest generalized lipoatrophy at birth
or until 2 years of age, and in adolescence usually develop marked insulin resistance
with rapid progression to diabetes and dyslipidemia. We report the case of a
17-year-old Berardinelli-Seip syndrome patient with eruptive xanthoma associated with
severe hypertriglyceridemia. It is worth noting Eruptive xanthoma as a dermatological
manifestation that is not generally highlighted in the reports of cases of this
genetic metabolic disorder.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>S&#xED;ndrome de Berardinelli-Seip &#xE9; doen&#xE7;a gen&#xE9;tica autoss&#xF4;mica recessiva rara,
caracterizada por inefici&#xEA;ncia em metabolizar e estocar material lip&#xED;dico
adequadamente nos adip&#xF3;citos, gerando ac&#xFA;mulo de gordura em &#xF3;rg&#xE3;os n&#xE3;o habituais,
como f&#xED;gado, ba&#xE7;o, p&#xE2;ncreas, cora&#xE7;&#xE3;o, endot&#xE9;lio arterial e pele. Classicamente, os
portadores nascem ou manifestam lipoatrofia generalizada at&#xE9; os 2 anos e, geralmente
na adolesc&#xEA;ncia, desenvolvem marcada resist&#xEA;ncia insul&#xED;nica com r&#xE1;pida progress&#xE3;o
para diabetes e dislipidemia. Relatamos um caso de portadora da s&#xED;ndrome de
Berardinelli-Seip, de 17 anos, com xantoma eruptivo associado &#xE0; hipertrigliceridemia
grave. Ressalta-se o xantoma eruptivo como manifesta&#xE7;&#xE3;o dermatol&#xF3;gica n&#xE3;o enfatizada
nos casos relatados sobre esse dist&#xFA;rbio metab&#xF3;lico gen&#xE9;tico.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Acanthosis nigricans</kwd>
        <kwd>Diabetes mellitus</kwd>
        <kwd>Dyslipidemias</kwd>
        <kwd>Lipodystrophy, congenital generalized</kwd>
        <kwd>Xanthomatosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>CASE REPORT</title>
      <p>A 17-year-old female patient was referred from the Endocrinology Department with
yellowish papules on her arms and legs for about a year.</p>
      <p>On examination, the patient presented acromegaloid fascies, generalized lipoatrophy,
phlebomegaly, hepatomegaly, axillary acanthosis nigricans, clitoromegaly, and yellowish
coalescing and isolated papules with an erythematous halo in the upper and lower limbs
(<xref ref-type="fig" rid="f01">Figure 1</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>
<bold>A:</bold> Generalized lipoatrophy leading to an athletic appearance.
<bold>B:</bold> Right elbow showing coalescing and isolated yellow papules with
erythematous halo. <bold>C:</bold> Phlebomegaly in the lower limbs</p>
        </caption>
        <graphic xlink:href="abd-88-06-1011-g01"/>
      </fig>
      <p>From birth, she presented a total absence of subcutaneous fat. At age 10, she had
impaired glucose tolerance which, because unchecked, had developed into diabetic
ketoacidosis in under one year. Subsequently, she presented type 2 diabetes mellitus
(DM) associated with dyslipidemia and hepatic steatosis. These disorders were not
responsive to the usual pharmacological doses, and required the administration of high
doses of exogenous insulin, oral hypoglycemic and hypolipidemic agents. Despite therapy,
tests showed fasting glucose level of 284 mg/dl; postprandial glucose, 423 mg/dl; total
cholesterol, 579 mg/dl; and triglycerides, 3.194 mg/dl. Histopathological examination
confirmed clinical hypothesis of eruptive xanthoma (<xref ref-type="fig" rid="f02">Figure 2</xref>).</p>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>
<bold>A:</bold> Palmar region showing yellowish papules with erythematous halo.
<bold>B:</bold> Rectified and epidermal inflammatory infiltrate composed of
lymphocytes and xanthomized histiocytes in upper and middle dermis.
(Hematoxylin&#x2013;eosin; 40&#xD7; magnification). <bold>C:</bold> Detail of xanthomized
histiocytes (hematoxylin&#x2013;eosin; 400&#xD7; magnification)</p>
        </caption>
        <graphic xlink:href="abd-88-06-1011-g02"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Berardinelli-Seip syndrome (BSS) or Berardinelli-Seip congenital lipoatrophy, is a rare
autosomal recessive genetic disease, with only up to 200 reported cases to
date.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref></sup> The first case was reported in Brazil in 1954 by
Berardinelli.<sup><xref ref-type="bibr" rid="r03">3</xref></sup> Four years later
in Norway, Seip described the cases of 3 patients. Since then, this disease has been
referred to as the Seip-Berardinelli syndrome.<sup><xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r05">5</xref></sup>
</p>
      <p>BSS is diagnosed in cases where 3 major criteria or 2 major criteria and 2 or more minor
criteria are met (<xref ref-type="table" rid="t01">Chart 1</xref>).<sup><xref ref-type="bibr" rid="r06">6</xref></sup>
</p>
      <table-wrap id="t01" orientation="portrait" position="float">
        <label>CHART 1</label>
        <caption>
          <p>Diagnostic criteria of BSCL</p>
        </caption>
        <table frame="box" rules="groups">
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">
<bold>Major Criteria</bold>
</td>
              <td rowspan="1" colspan="1">
<bold>Minor Criteria</bold>
</td>
            </tr>
            <tr>
              <td rowspan="2" colspan="1">&#x2022; Lipoatrophy affecting the trunk, limbs, and face</td>
              <td rowspan="2" colspan="1">&#x2022; Hypertrophic cardio- myopathy</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">&#x2022; Acromegalic appearance (gigantism, prog- nathism, muscle hypertrophy
leading to an athletic appearance, advanced bone age, increased size of
hands and feet, clitorome- galy or increased size of external genitalia in
men</td>
              <td rowspan="1" colspan="1">&#x2022; Mild (IQ, 50-70) to moderate psychomo- tor retardation (IQ<sup><xref ref-type="table-fn" rid="t01-fn01">*</xref></sup>, 35-50)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">&#x2022; Hepatomegaly</td>
              <td rowspan="1" colspan="1">&#x2022; Hirsutism</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">&#x2022; Increased serum triglycerides (sometimes associated with
hypercholesterolemia)</td>
              <td rowspan="1" colspan="1">&#x2022; Early puberty in girls</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">&#x2022; Insulin resistance (increase in serum C- peptide and insulin
levels)\acanthosis nigricans</td>
              <td rowspan="1" colspan="1">&#x2022; Bone cysts</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">&#xA0;</td>
              <td rowspan="1" colspan="1">&#x2022; Phlebomegaly</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn>
            <p><bold>Source:</bold> Khandpur S, et al. <sup><xref ref-type="bibr" rid="r06">6</xref></sup></p>
          </fn>
          <fn id="t01-fn01">
            <label>*</label>
            <p><bold>IQ:</bold> intelligence quotient.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>The pathogenic mechanism of SBS is related to inefficiency in metabolizing and storing
lipid material and is represented by generalized lipoatrophy, hirsutism and acanthosis
nigricans.<sup><xref ref-type="bibr" rid="r07">7</xref></sup>
</p>
      <p>Classically these patients develop progressive peripheral insulin resistance, with rapid
evolution for diabetes type 2, as in our patient, whose Diabetic Ketoacidosis was
manifested at 10 years old. Early development of atherosclerosis can be observed as well
as non-alcoholic fatty liver disease (often progressing to liver cirrhosis), and type V
dyslipidemia (Fredrickson classification), which is represented by increased serum
chylomicrons, very low-density lipoproteins (VLDL), and triglyceride levels.<sup><xref ref-type="bibr" rid="r08">8</xref></sup>
</p>
      <p>Our patient showed 5 major diagnostic criteria and one minor criterion (<xref ref-type="table" rid="t01">Chart 1</xref>).</p>
      <p>Eruptive xanthoma is characterized by the appearance of yellowish papules with
erythematous halo arising from the deposition of increased blood triglycerides in the
skin. The papulae are generally observed around the buttocks and extensor surfaces of
the extremities. These papulae occur in BSS patients with chylomicronemia and
hypertriglyceridemia, and these could be caused by either lipase deficiency or
hyperlipidemia type V.<sup><xref ref-type="bibr" rid="r08">8</xref></sup> Furthermore,
this could lead to eruptive xanthomas, as previously shown in the case of a Brazilian
BSS patient.<sup><xref ref-type="bibr" rid="r09">9</xref></sup> Despite this condition
being an expected cutaneous manifestation in patients with severe and resistant type of
dyslipidemia, the medical literature has not highlighted this aspect of cutaneous
syndrome. This may indicate that the majority of studies have been conducted in the
fields of metabolism and genetics. However, we consider these cutaneous manifestations
important and assume that xanthomas are predictors of lipid dysregulation.</p>
      <p>The therapy that we administered restricted lipid intake and increased the intake of
polyunsaturated fats. We also employed medical management of dyslipidemia associated
with insulin resistance or diabetes and closely monitored the liver and cardiovascular
system to prevent fatal liver and cardiological complications.<sup><xref ref-type="bibr" rid="r01">1</xref></sup>
</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p> Work performed at the Pedro Ernesto University Hospital - Rio de Janeiro State
University, Rio de Janeiro (RJ), Brazil.</p>
      </fn>
      <fn id="fn02" fn-type="financial-disclosure">
        <p>Financial Support: None.</p>
      </fn>
      <fn id="fn03" fn-type="conflict">
        <p>Conflict of Interests: None.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garg</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Acquired and inhereited lipodysthrofies</article-title>
          <source>N Engl J Med</source>
          <year>2004</year>
          <volume>350</volume>
          <fpage>1220</fpage>
          <lpage>1234</lpage>
          <pub-id pub-id-type="pmid">15028826</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Agarwal</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Garg</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Genetic disorders of adipose tissue development, differentiation, and
death</article-title>
          <source>Annu Rev Genomics Hum Genet</source>
          <year>2006</year>
          <volume>7</volume>
          <fpage>175</fpage>
          <lpage>199</lpage>
          <pub-id pub-id-type="pmid">16722806</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berardinelli</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>An undiagnosed endocrinometabolic syndrome: report of 2
cases</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>1954</year>
          <volume>14</volume>
          <fpage>193</fpage>
          <lpage>204</lpage>
          <pub-id pub-id-type="pmid">13130666</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seip</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Lipodystrophy and gigantismo with associated endocrinone
manifestation: a new diencephalic syndrome? </article-title>
          <source>Acta Paediatr</source>
          <year>1959</year>
          <volume>48</volume>
          <fpage>555</fpage>
          <lpage>574</lpage>
          <pub-id pub-id-type="pmid">14444642</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seip</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Trygstad</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Generalized lipodystrophy</article-title>
          <source>Arch Dis Child</source>
          <year>1963</year>
          <volume>38</volume>
          <fpage>447</fpage>
          <lpage>453</lpage>
          <pub-id pub-id-type="pmid">14065985</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khandpur</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Khadgawat</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Congenital generalized lipodystrophy of Berardinelli-Seip type: A rare
case</article-title>
          <source>Indian J Dermatol Venereol Leprol</source>
          <year>2011</year>
          <volume>77</volume>
          <fpage>402</fpage>
          <lpage>402</lpage>
          <pub-id pub-id-type="pmid">21508592</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haque</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Garg</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Agarwal</surname>
              <given-names>AK</given-names>
            </name>
          </person-group>
          <article-title>Enzimatic activity of naturally occurring 1-acylglycerol-
3-phosphate-0-acyltransferase 2 Mutants Associated with Generalized
Lipodysthrophy</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2005</year>
          <volume>327</volume>
          <fpage>446</fpage>
          <lpage>453</lpage>
          <pub-id pub-id-type="pmid">15629135</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Naik</surname>
              <given-names>S N</given-names>
            </name>
          </person-group>
          <article-title>Eruptive xanthomas</article-title>
          <source>Dermatol Online J</source>
          <year>2001</year>
          <volume>7</volume>
          <fpage>11</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="pmid">12165227</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sousa</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Vale</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Voc&#xEA; conhece esta s&#xED;ndrome?</article-title>
          <source>An Bras Dermatol</source>
          <year>2006</year>
          <volume>81</volume>
          <fpage>87</fpage>
          <lpage>90</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
